Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 1.00 |
| ▸ | MEN1 | O00255 | 4/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 4/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 1.00 |
| ▸ | THRB | P10828 | 3/20 | 1.00 |
| ▸ | RECQL | P46063 | 3/20 | 1.00 |
| ▸ | USP2 | O75604 | 3/20 | 1.00 |
| ▸ | POLB | P06746 | 2/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 1.00 |
| ▸ | GAA | P10253 | 1/20 | 1.00 |
| ▸ | CACNA1B | Q00975 | 1/20 | 1.00 |
| ▸ | APBA1 | Q02410 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.77 |
| ▸ | HPGD | P15428 | 3/20 | 0.77 |
| ▸ | PHPT1 | Q9NRX4 | 2/20 | 0.77 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.77 |
| ▸ | CASP1 | P29466 | 1/20 | 0.77 |
| ▸ | MED25 | Q71SY5 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17694852 | 0.93 | KDM4E (0.87) | MAPTKDM4EMEN1ALDH1A1KMT2A | |
| SCHEMBL15581642 | 0.92 | MAPT (0.85) | MAPTKDM4EMEN1ALDH1A1KMT2A | |
| Norstictic Acid SCHEMBL29369714 | 0.87 | MAPT (1.00) | MAPTKDM4EMEN1ALDH1A1KMT2A | |
| Norstictic Acid SCHEMBL13287269 | 0.87 | MAPT (1.00) | MAPTKDM4EMEN1ALDH1A1KMT2A | |
| SCHEMBL30509240 | 0.87 | KDM4E (0.76) | MAPTKDM4EMEN1ALDH1A1KMT2A | |
| SCHEMBL15581643 | 0.78 | KDM4E (0.66) | MAPTKDM4EMEN1ALDH1A1KMT2A | |
| SCHEMBL17988248 | 0.78 | MAPT (0.72) | MAPTKDM4EMEN1ALDH1A1KMT2A | |
| Stictic Acid SCHEMBL13495711 | 0.76 | KDM4E (1.00) | MAPTKDM4EMEN1ALDH1A1KMT2A | |
| Stictic Acid SCHEMBL29394416 | 0.76 | KDM4E (1.00) | MAPTKDM4EMEN1ALDH1A1KMT2A | |
| SCHEMBL17975303 | 0.75 | MAPT (0.65) | MAPTKDM4EMEN1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9750742-B2 | Small molecular inhibitors of RAD51 recombinase and methods thereof | DREXEL UNIVERSITY (US) | 2017-09-05 | — | — | US | claimed |
| US-20160106751-A1 | SMALL MOLECULAR INHIBITORS OF RAD51 RECOMBINASE AND METHODS THEREOF | DREXEL UNIVERSITY (US) | 2016-04-21 | — | — | US | claimed |
| US-20140080849-A1 | Small Molecular Inhibitors of RAD51 Recombinase and Methods Thereof | Philadelphia Health & Education Ccorporation d/b/a Drexel University College of Medicine (US) | 2014-03-20 | — | — | US | claimed |
| JP-2223520-A | — | — | None | — | — | JP | disclosed |
| US-20250368695-A1 | Atranorin biosynthesis gene derived from lichens and uses thereof | INDUSTRY ACADEMIC COOPERATION FOUNDATION OF SUNCHON NATIONAL UNIV (KR) | 2025-12-04 | — | — | US | disclosed |
| WO-2022260402-A1 | ATRANORIN BIOSYNTHESIS GENE DERIVED FROM LICHEN AND USE THEREOF | 순천대학교 산학협력단 | 2022-12-15 | — | — | WO | disclosed |
| US-10207988-B2 | Methods and compositions for treatment of cancer and autoimmune disease | THE JACKSON LABORATORY (US) | 2019-02-19 | — | — | US | disclosed |
| US-10207988-B2 | Methods and compositions for treatment of cancer and autoimmune disease | THE JACKSON LABORATORY (US) | 2019-02-19 | — | — | US | disclosed |
| CN-108391659-A | A kind of plant transpiration resistant agent and preparation method thereof | 天津市德宇生物工程技术有限公司 | 2018-08-14 | — | — | CN | disclosed |
| US-9750742-B2 | Small molecular inhibitors of RAD51 recombinase and methods thereof | DREXEL UNIVERSITY (US) | 2017-09-05 | — | — | US | disclosed |
| US-9750742-B2 | Small molecular inhibitors of RAD51 recombinase and methods thereof | DREXEL UNIVERSITY (US) | 2017-09-05 | — | — | US | disclosed |
| CN-101798244-A | Multifunctional transpiration inhibitor | BEIJING GREEN SINGLARITY SCIENCE & TECHNOLOGY DEV CO LTD | 2010-08-11 | — | — | CN | disclosed |
| CN-101731277-A | Method for preparing plant transpiration suppression material and using method thereof | ENVIRONMENT AND SUSTAINABLE DE | 2010-06-16 | — | — | CN | disclosed |
| CN-101417901-A | Multifunctional antitranspirant and preparation method thereof | BEIJING LUSEQIDIAN TECHNOLOGY (CN) | 2009-04-29 | — | — | CN | disclosed |
| EP-1675020-A2 | Parser | Xerox Corporation (US) | 2006-06-28 | — | — | EP | disclosed |
| US-20060136196-A1 | Bi-dimensional rewriting rules for natural language processing | XEROX CORPORATION | 2006-06-22 | — | — | US | disclosed |
| CN-1500520-A | Lichen bacteriophage and its production method thereof | 大兴安岭林格贝有机食品有限责任公司 | 2004-06-02 | — | — | CN | disclosed |
| JP-H02223520-A | VASODILATOR COMPRISING DEPSIDONE | KAO CORP | 1990-09-05 | — | — | JP | disclosed |
| US-4937195-A | SYMBIOTIC ASSOCIATION OF FUNGUS CELL AND ALGAL CELL | NIPPON PAINT CO., LTD. (JP) | 1990-06-26 | — | — | US | disclosed |
| US-4536474-A | SYMBIOTIC MIXTURE OF ALGAE AND FUNGI | NIPPON PAINT CO., LTD. (JP) | 1985-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160106751-A1 | SMALL MOLECULAR INHIBITORS OF RAD51 RECOMBINASE AND METHODS THEREOF | RAD51, MRE11, BRCA1 | MAPT 3439/4885KDM4E 2087/4885MEN1 1277/4885 |
| US-20140080849-A1 | Small Molecular Inhibitors of RAD51 Recombinase and Methods Thereof | RAD51, MRE11, BRCA1 | MAPT 3439/4885KDM4E 2087/4885MEN1 1277/4885 |
| US-10207988-B2 | Methods and compositions for treatment of cancer and autoimmune disease | BAK1, SSB, MRE11 | MAPT 3931/4885KDM4E 2402/4885MEN1 1722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.